Controversial Oregon cannabis executive charged with tax fraud
An Oregon cannabis MSO CEO faces federal tax fraud charges, highlighting critical financial compliance risks for industr…
Read more →Beyond 280E relief: The hidden tax audit risks of marijuana rescheduling
Cannabis rescheduling offers Section 280E relief but brings hidden tax audit risks. Operators must audit historical reco…
Read more →
DEA Judge Orders Agency To Address Marijuana Rescheduling Opponents’ Request For New Testimony And Document Discovery
DEA judge orders agency response on rescheduling testimony and discovery following a federal report highlighting evaluat…
Read more →
DEA Is OK With Including New Report In Marijuana Rescheduling Hearing As Opponents Seek More Testimony And Document Discovery
DEA agrees to include a federal watchdog report in marijuana rescheduling hearings while resisting calls for additional …
Read more →
The Marijuana Rescheduling Process Has Been Delayed—But Not Derailed (Op-Ed)
Legal experts clarify that DEA marijuana rescheduling delays are procedural, meaning Section 280E tax burdens will remai…
Read more →
Feds And Marijuana Opponents Agree On Briefing Schedule In Lawsuit Challenging Trump’s Reclassification Move
DOJ and marijuana opponents agree on a briefing schedule in a lawsuit challenging federal cannabis rescheduling, impacti…
Read more →Federal marijuana rescheduling means institutional capital is coming to cannabis investing
Federal marijuana rescheduling is bringing institutional capital to cannabis investing. Learn how Schedule III changes f…
Read more →
Iowa Democratic Gubernatorial Candidate Praises Trump For Rescheduling Marijuana
Iowa Democratic gubernatorial nominee Rob Sand praises Trump administration marijuana rescheduling efforts, highlighting…
Read more →
Federal Officials Say Marijuana Industry Tax Guidance Will Be A ‘Priority’ For The Next Year
Federal officials prioritize cannabis tax guidance following Schedule III rescheduling plans, signaling major financial …
Read more →
DEA Judge Puts Federal Cannabis Rescheduling Process on Pause
DEA judge pauses cannabis rescheduling hearings to review a GAO report highlighting procedural flaws at the DEA and FDA.
Read more →New delay for federal marijuana rescheduling as flaws in process parsed
Federal marijuana rescheduling faces new delays as the DEA reviews procedural flaws, extending tax and regulatory uncert…
Read more →DEA judge grants cannabis opponents’ request to pause rescheduling hearing (Newsletter: September 30, 2026)
DEA judge pauses cannabis rescheduling hearings, delaying federal reform timelines. Get key updates on policy, state mar…
Read more →Illinois adult-use cannabis retailers scoop up MMJ permits
Illinois adult-use retailers are securing medical marijuana permits under SB 3222, providing crucial 280E tax relief and…
Read more →Trump medical marijuana rescheduling order survives initial challenge
Initial legal challenge to federal marijuana rescheduling survives, keeping the process moving forward while broader lit…
Read more →Court allows cannabis rescheduling to proceed (Newsletter: September 10, 2026)
Court allows cannabis rescheduling to move forward, MA hits $10B in sales, and feds issue travel warnings. Read the busi…
Read more →
New Hampshire Rep. Says During Primary Debate She Would Back Federal Cannabis Legalization
NH Rep. Maggie Goodlander backs federal cannabis legalization during primary debate, signaling potential shifts for regi…
Read more →
Trump Releases More Federal Marijuana Prisoners As DEA Considers Rescheduling Cannabis
Trump commutes federal marijuana sentences as the DEA reviews cannabis rescheduling. What this federal policy shift mean…
Read more →
Federal Rescheduling Sets The Stage For Marijuana Business Acquisitions As Pharma And Ag Firms Eye Industry (Op-Ed)
Federal marijuana rescheduling paves the way for M&A activity as pharma and ag firms eye the cannabis industry. What ope…
Read more →Marijuana rescheduling decision nears as DEA publishes hearing transcript
DEA publishes marijuana rescheduling hearing transcript as Judge Derek Julius weighs a Schedule 3 recommendation affecti…
Read more →
How Cannabis Companies Can Take Advantage Of The Research And Development Tax Credit Under Federal Rescheduling (Op-Ed)
Learn how federal cannabis rescheduling could allow marijuana companies to access valuable Research and Development Tax …
Read more →
Feds Aren’t Answering States’ Questions On Marijuana Rescheduling Process, South Dakota Official Says
South Dakota officials report federal silence on marijuana rescheduling details, leaving state cannabis operators facing…
Read more →Lawmakers press Trump for cannabis rescheduling guidance (Newsletter: August 20, 2026)
Lawmakers press for federal cannabis rescheduling guidance while New Hampshire advances greenhouse cultivation and new m…
Read more →
Why DEA’s Marijuana Rescheduling Proposal May Be DOA Under The Trump Administration (Op-Ed)
Analysis of how the incoming Trump administration could impact the DEA's proposed cannabis rescheduling rule and what it…
Read more →
DEA And Anti-Marijuana Groups File Final Briefs In Hearing On Trump Administration Rescheduling Proposal
DEA and prohibitionist groups file final briefs in cannabis rescheduling hearings, setting the stage for the judge's rec…
Read more →Illinois adult-use cannabis retailers can apply for medical permits, with DEA and tax benefits possible
Illinois adult-use retailers can now apply for medical permits, potentially unlocking DEA registration eligibility and f…
Read more →How federal marijuana rescheduling rewrites the rules for cannabis business leases
Federal rescheduling to Schedule III allows cannabis businesses to deduct rent from federal taxes, necessitating updates…
Read more →
NORML Op-Ed: High Time to Remove Cannabis from Schedule I Status
NORML argues for the removal of cannabis from Schedule I, citing scientific and public pressure to modernize federal pol…
Read more →Alabama may opt out of federal marijuana rescheduling. What happens next?
Alabama's potential resistance to federal marijuana rescheduling creates tax and regulatory uncertainty for cannabis bus…
Read more →Pharma Company And Drug Testing Industry Claim Trump’s Rescheduling Move Will ‘Increase Marijuana Abuse’
Pharma and drug testing firms sue to block cannabis rescheduling, citing public health concerns and potential delays for…
Read more →Marijuana Companies Donated $11.5 Million To Trump-Linked PAC Last Month, New Campaign Finance Records Show
Major cannabis firms donated $11.5M to a Trump-linked PAC. Explore what this massive shift in industry lobbying means fo…
Read more →